NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

The company came already with a key customer, if not others even probably, and was a spin-off of Cognate. It came with the know how to do a high margin business. But it doesn’t change the fact that both are legitimate, separate businesses that by definition are used by small companies like this routinely to isolate long-term costs and other risks on another balance sheet.

Given how Dendreon blew up, it seems to me the company has very carefully managed those costs, has a partner that they can share information with without a high degree of competitive risks, and they can manage and even subsidize the costs of their facility given the special deal they put together with the regional development authority utilizing Advent as a regional service provider within NWBO’s facility to service other companies and even become a self-sustaining resource when not in use by the company.

Take a company with its own facilities and well capitalized, you’d have to pay them just to send personnel to your factory and be there, not even covering the cost of developing the factory. It’s an innovative symbiosis that helps subsidize the low burn rate even though they have a licensed commercial manufacturing plant.

But you keep screaming that they should be just like Dendreon…. Cause shorts made a lot of money riding that one down based on the plants and manufacturing costs swamping the company. We see you….